Drug Shortage Report for KADIAN

Last updated on 2018-04-04 History
Report ID 30923
Drug Identification Number 02184451
Brand name KADIAN
Common or Proper name KADIAN
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) MORPHINE SULFATE
Strength(s) 100MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL
Packaging size 50
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-04-03
Actual start date 2018-03-29
Estimated end date 2018-04-06
Actual end date 2018-04-03
Shortage status Resolved
Updated date 2018-04-04
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v27 2018-03-08 French Compare
v26 2018-03-08 English Compare
v25 2018-03-06 French Compare
v24 2018-03-06 English Compare
v23 2018-02-23 English Compare
v22 2018-02-22 French Compare
v21 2018-02-22 English Compare
v20 2018-02-20 French Compare
v19 2018-02-20 English Compare
v18 2018-02-20 French Compare
v17 2018-02-20 English Compare
v16 2018-02-12 French Compare
v15 2018-02-12 English Compare
v14 2018-01-15 French Compare
v13 2018-01-15 English Compare
v12 2018-01-08 French Compare
v11 2018-01-08 English Compare
v10 2017-12-30 English Compare
v9 2017-12-29 French Compare
v8 2017-12-29 English Compare

Showing 21 to 40 of 47